BERLIN, Feb 1 (Reuters) - German medicine container
maker Schott Pharma is no longer seeking a strategic investor
and now plans to float part of the company while leaving the
existing owners in control, its chief executive told the
Frankfurter Allgemeine newspaper.
The Mainz, western Germany-based company is one of the
world's largest makers of glass and plastic containers used for
medicines and vaccines, selling some 13 billion ampules,
syringes and phials each year.
"Now, we're only looking to a flotation," Chief Executive
Frank Heinricht was quoted as saying on Tuesday.
The company's turnover rose 27% last year to 821 million
euros.
(Reporting by Thomas Escritt
Editing by Bernadette Baum)
@thomasescritt@berlin.social; +49 30 2201 33579;))
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.